• News
  • SAN DIEGO
  • BioTech

Mallinckrodt buying Questcor for about $5.6B

Mallinckrodt is buying California-based Questcor Pharmaceuticals Inc. for a combination of stock and cash valued at about $5.6 billion that will help to further diversify the Irish company's business.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!